Literature DB >> 19086085

Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.

Christopher G Goetz1, Glenn T Stebbins, David Wolff, William DeLeeuw, Helen Bronte-Stewart, Rodger Elble, Mark Hallett, John Nutt, Lorraine Ramig, Terence Sanger, Allan D Wu, Peter H Kraus, Lucia M Blasucci, Ejaz A Shamim, Kapil D Sethi, Jennifer Spielman, Ken Kubota, Andrew S Grove, Eric Dishman, C Barr Taylor.   

Abstract

We tested the feasibility of a computer based at-home testing device (AHTD) in early-stage, unmedicated Parkinson's disease (PD) patients over 6 months. We measured compliance, technical reliability, and patient satisfaction to weekly assessments of tremor, small and large muscle bradykinesia, speech, reaction/movement times, and complex motor control. relative to the UPDRS motor score. The AHTD is a 6.5'' x 10'' computerized assessment battery. Data are stored on a USB memory stick and sent by internet to a central data repository as encrypted data packets. Although not designed or powered to measure change, the study collected data to observe patterns relative to UPDRS motor scores. Fifty-two PD patients enrolled, and 50 completed the 6 month trial, 48 remaining without medication. Patients complied with 90.6% of weekly 30-minute assessments, and 98.5% of data packets were successfully transmitted and decrypted. On a 100-point scale, patient satisfaction with the program at study end was 87.2 (range: 80-100). UPDRS motor scores significantly worsened over 6 months, and trends for worsening over time occurred for alternating finger taps (P = 0.08), tremor (P = 0.06) and speech (P = 0.11). Change in tremor was a significant predictor of change in UPDRS (P = 0.047) and was detected in the first month of the study. This new computer-based technology offers a feasible format for assessing PD-related impairment from home. The high patient compliance and satisfaction suggest the feasibility of its incorporation into larger clinical trials, especially when travel is difficult and early changes or frequent data collection are considered important to document.

Entities:  

Mesh:

Year:  2009        PMID: 19086085      PMCID: PMC4161502          DOI: 10.1002/mds.22379

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Quantitative digitography (QDG): a sensitive measure of digital motor control in idiopathic Parkinson's disease.

Authors:  H M Bronte-Stewart; L Ding; C Alexander; Y Zhou; G P Moore
Journal:  Mov Disord       Date:  2000-01       Impact factor: 10.338

Review 2.  Overcoming barriers to recruitment in health research.

Authors:  Jenny Hewison; Andy Haines
Journal:  BMJ       Date:  2006-08-05

3.  Barriers to clinical trials vary according to the type of trial and the institution.

Authors:  Rangaswamy Govindarajan; James W Young; Cherie L Harless; Laura F Hutchins
Journal:  J Clin Oncol       Date:  2007-04-20       Impact factor: 44.544

Review 4.  Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

5.  Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

Authors:  L O Ramig; S Sapir; S Countryman; A A Pawlas; C O'Brien; M Hoehn; L L Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.

Authors:  Peter H Kraus; Peter Klotz; Arndt Hoffmann; Johannes Lewe; Horst Przuntek
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

7.  A new actigraph for long-term registration of the duration and intensity of tremor and movement.

Authors:  E J van Someren; B F Vonk; W A Thijssen; J D Speelman; P R Schuurman; M Mirmiran; D F Swaab
Journal:  IEEE Trans Biomed Eng       Date:  1998-03       Impact factor: 4.538

Review 8.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

9.  Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.

Authors:  Christopher G Goetz; Sue Leurgans; Vanessa K Hinson; Lucia M Blasucci; Jennifer Zimmerman; Wenqing Fan; Tiffany Nguyen; Ann Hsu
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

10.  Movement and reaction times and fine coordination tasks following pallidotomy.

Authors:  J Jankovic; L Ben-Arie; K Schwartz; K Chen; M Khan; E C Lai; J K Krauss; R Grossman
Journal:  Mov Disord       Date:  1999-01       Impact factor: 10.338

View more
  44 in total

1.  Validation of a home environment test battery for supporting assessments in advanced Parkinson's disease.

Authors:  Jerker Westin; Mauro Schiavella; Mevludin Memedi; Dag Nyholm; Mark Dougherty; Angelo Antonini
Journal:  Neurol Sci       Date:  2011-11-09       Impact factor: 3.307

2.  Parkinson disease assessment feasible with an at-home testing device.

Authors: 
Journal:  Nat Clin Pract Neurol       Date:  2009-03

3.  Quantitative Motor Performance and Sleep Benefit in Parkinson Disease.

Authors:  Merel M van Gilst; Petra van Mierlo; Bastiaan R Bloem; Sebastiaan Overeem
Journal:  Sleep       Date:  2015-10-01       Impact factor: 5.849

Review 4.  The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach.

Authors:  H Ben-Pazi; P Browne; P Chan; E Cubo; M Guttman; A Hassan; J Hatcher-Martin; Z Mari; E Moukheiber; N U Okubadejo; A Shalash
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-13       Impact factor: 5.081

5.  The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Authors:  Marissa Giovanna Schamne; Josiel Mileno Mack; Morgana Moretti; Filipe Carvalho Matheus; Roger Walz; Laurence Lanfumey; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2018-05-28       Impact factor: 3.911

6.  Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's disease.

Authors:  Thomas Müller; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2020-02-01       Impact factor: 3.575

Review 7.  Transducer-based evaluation of tremor.

Authors:  Dietrich Haubenberger; Giovanni Abbruzzese; Peter G Bain; Nin Bajaj; Julián Benito-León; Kailash P Bhatia; Günther Deuschl; Maria João Forjaz; Mark Hallett; Elan D Louis; Kelly E Lyons; Tiago A Mestre; Jan Raethjen; Maria Stamelou; Eng-King Tan; Claudia M Testa; Rodger J Elble
Journal:  Mov Disord       Date:  2016-06-06       Impact factor: 10.338

8.  Diadochokinetic movements differ between patients with Parkinson's disease and controls.

Authors:  Thomas Müller; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2009-11-10       Impact factor: 3.575

9.  Objective quantification of neuromotor symptoms in Parkinson's disease: implementation of a portable, computerized measurement tool.

Authors:  Spyridon Papapetropoulos; Heather L Katzen; Blake K Scanlon; Alexandra Guevara; Carlos Singer; Bonnie E Levin
Journal:  Parkinsons Dis       Date:  2010-06-30

10.  Randomized controlled clinical trial of "virtual house calls" for Parkinson disease.

Authors:  E Ray Dorsey; Vinayak Venkataraman; Matthew J Grana; Michael T Bull; Benjamin P George; Cynthia M Boyd; Christopher A Beck; Balaraman Rajan; Abraham Seidmann; Kevin M Biglan
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.